Dotarem + Gadovist
ApprovedCompleted 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Peripheral Arterial Disease
Conditions
Peripheral Arterial Disease
Trial Timeline
Oct 1, 2009 → Jan 1, 2012
NCT ID
NCT01026389About Dotarem + Gadovist
Dotarem + Gadovist is a approved stage product being developed by Guerbet for Peripheral Arterial Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT01026389. Target conditions include Peripheral Arterial Disease.
Hype Score Breakdown
Clinical
30
Activity
20
Company
2
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01026389 | Approved | Completed |
Competing Products
20 competing products in Peripheral Arterial Disease